TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Riz, Irene ^a   Hawley, Teresa S ^a   Luu, Truong V ^a   Lee, Norman H ^a   Hawley, Robert G ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CD1B ANTIGEN; HIGH MOBILITY GROUP A2 PROTEIN; HOMEODOMAIN PROTEIN; MYC PROTEIN; NOTCH RECEPTOR; PLACENTA PROTEIN; PLACENTA PROTEIN 8; RAG1 PROTEIN; T CELL LEUKEMIA HOMEOBOX 1; UNCLASSIFIED DRUG; ONCOPROTEIN; TLX1 PROTEIN, HUMAN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CELL EXPANSION; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; DEVELOPMENTAL GENE; DOWN REGULATION; EARLY RESPONSE GENE; EMBRYO; GENE ACTIVITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE REGULATORY NETWORK; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC GAIN; GROWTH REGULATION; HOMEOBOX; HUMAN; HUMAN CELL; LEUKEMIA CELL; LOSS OF FUNCTION MUTATION; LYMPHOCYTE DIFFERENTIATION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REPRESSOR GENE; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; THYMOCYTE; TRANSCRIPTION REGULATION; TUMOR PROMOTION; CELL DIVISION; GENETIC TRANSCRIPTION; GENETICS; PATHOLOGY; PHYSIOLOGY;

CELL DIVISION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS; RECEPTORS, NOTCH; TRANSCRIPTION, GENETIC;

EID: 77954335639     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-181     Document Type: Article

References (104)

1. Hueber SD, Bezdan D, Henz SR, Blank M, Wu H, Lohmann I. Comparative analysis of Hox downstream genes in Drosophila. Development 2007, 134:381-392. 10.1242/dev.02746, 17166915.
2. Hombria JC, Lovegrove B. Beyond homeosis--HOX function in morphogenesis and organogenesis. Differentiation 2003, 71:461-476. 10.1046/j.1432-0436.2003.7108004.x, 14641327.
3. Owens BM, Hawley RG. HOX and non-HOX homeobox genes in leukemic hematopoiesis. Stem Cells 2002, 20:364-379. 10.1634/stemcells.20-5-364, 12351808.
4. Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer 2010, 10:361-371. 10.1038/nrc2826, 20357775.
5. Holland PW, Booth HA, Bruford EA. Classification and nomenclature of all human homeobox genes. BMC Biol 2007, 5:47. 10.1186/1741-7007-5-47, 2211742, 17963489.
6. Roberts CW, Shutter JR, Korsmeyer SJ. Hox11 controls the genesis of the spleen. Nature 1994, 368:747-749. 10.1038/368747a0, 7908720.
7. Cheng L, Arata A, Mizuguchi R, Qian Y, Karunaratne A, Gray PA, Arata S, Shirasawa S, Bouchard M, Luo P, Chen CL, Busslinger M, Goulding M, Onimaru H, Ma Q. Tlx3 and Tlx1 are post-mitotic selector genes determining glutamatergic over GABAergic cell fates. Nat Neurosci 2004, 7:510-517. 10.1038/nn1221, 15064766.
8. Aifantis I, Raetz E, Buonamici S. Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 2008, 8:380-390. 10.1038/nri2304, 18421304.
9. Hawley RG, Fong AZC, Lu M, Hawley TS. The HOX11 homeobox-containing gene of human leukemia immortalizes murine hematopoietic precursors. Oncogene 1994, 9:1-12.
10. Hawley RG, Fong AZC, Reis MD, Zhang N, Lu M, Hawley TS. Transforming function of the HOX11/TCL3 homeobox gene. Cancer Res 1997, 57:337-345.
11. Weng AP, Ferrando AA, Lee W, Morris JP, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT, Aster JC. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004, 306:269-271. 10.1126/science.1102160, 15472075.
12. Aster JC, Pear WS, Blacklow SC. Notch signaling in leukemia. Annu Rev Pathol 2008, 3:587-613. 10.1146/annurev.pathmechdis.3.121806.154300, 18039126.
13. Asnafi V, Buzyn A, Le NS, Baleydier F, Simon A, Beldjord K, Reman O, Witz F, Fagot T, Tavernier E, Turlure P, Leguay T, Huguet F, Vernant JP, Daniel F, Bene MC, Ifrah N, Thomas X, Dombret H, Macintyre E. NOTCH1FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. Blood 2009, 113:3918-3924. 10.1182/blood-2008-10-184069, 19109228.
14. Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A, Barnes KC, O'Neil J, Neuberg D, Weng AP, Aster JC, Sigaux F, Soulier J, Look AT, Young RA, Califano A, Ferrando AA. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci USA 2006, 103:18261-18266. 10.1073/pnas.0606108103, 1838740, 17114293.
15. Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, Wai C, Del BC, Rodriguez CG, Sai H, Tobias J, Li Y, Wolfe MS, Shachaf C, Felsher D, Blacklow SC, Pear WS, Aster JC. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev 2006, 20:2096-2109. 10.1101/gad.1450406, 1536060, 16847353.
16. Chan SM, Weng AP, Tibshirani R, Aster JC, Utz PJ. Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia. Blood 2007, 110:278-286. 10.1182/blood-2006-08-039883, 1896117, 17363738.
17. Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M, Caparros E, Buteau J, Brown K, Perkins SL, Bhagat G, Agarwal AM, Basso G, Castillo M, Nagase S, Cordon-Cardo C, Parsons R, Zuniga-Pflucker JC, Dominguez M, Ferrando AA. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 2007, 13:1203-1210. 10.1038/nm1636, 2600418, 17873882.
18. Vilimas T, Mascarenhas J, Palomero T, Mandal M, Buonamici S, Meng F, Thompson B, Spaulding C, Macaroun S, Alegre ML, Kee BL, Ferrando A, Miele L, Aifantis I. Targeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia. Nat Med 2007, 13:70-77. 10.1038/nm1524, 17173050.
19. Buonamici S, Trimarchi T, Ruocco MG, Reavie L, Cathelin S, Mar BG, Klinakis A, Lukyanov Y, Tseng JC, Sen F, Gehrie E, Li M, Newcomb E, Zavadil J, Meruelo D, Lipp M, Ibrahim S, Efstratiadis A, Zagzag D, Bromberg JS, Dustin ML, Aifantis I. CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia. Nature 2009, 459:1000-1004. 10.1038/nature08020, 19536265.
20. Radtke F, Wilson A, Mancini SJ, MacDonald HR. Notch regulation of lymphocyte development and function. Nat Immunol 2004, 5:247-253. 10.1038/ni1045, 14985712.
21. Maillard I, Fang T, Pear WS. Regulation of lymphoid development differentiation, and function by the Notch pathway. Annu Rev Immunol 2005, 23:945-974. 10.1146/annurev.immunol.23.021704.115747, 15771590.
22. Staal FJ, Weerkamp F, Langerak AW, Hendriks RW, Clevers HC. Transcriptional control of T lymphocyte differentiation. Stem Cells 2001, 19:165-179. 10.1634/stemcells.19-3-165, 11359942.
23. Carrasco YR, Navarro MN, de Yebenes V, Ramiro AR, Toribio ML. Regulation of surface expression of the human pre-T cell receptor complex. Semin Immunol 2002, 14:325-334. 10.1016/S1044-5323(02)00065-9, 12220933.
24. Ciofani M, Schmitt TM, Ciofani A, Michie AM, Cuburu N, Aublin A, Maryanski JL, Zúñiga-Pflücker JC. Obligatory role for cooperative signaling by pre-TCR and Notch during thymocyte differentiation. J Immunol 2004, 172:5230-5239.
25. Rothenberg EV. Negotiation of the T lineage fate decision by transcription-factor interplay and microenvironmental signals. Immunity 2007, 26:690-702. 10.1016/j.immuni.2007.06.005, 17582342.
26. Maillard I, Tu L, Sambandam A, Yashiro-Ohtani Y, Millholland J, Keeshan K, Shestova O, Xu L, Bhandoola A, Pear WS. The requirement for Notch signaling at the β-selection checkpoint in vivo is absolute and independent of the pre-T cell receptor. J Exp Med 2006, 203:2239-2245. 10.1084/jem.20061020, 2118105, 16966428.
27. Ciofani M, Zúñiga-Pflücker JC. Notch promotes survival of pre-T cells at the β-selection checkpoint by regulating cellular metabolism. Nat Immunol 2005, 6:881-888. 10.1038/ni1234, 16056227.
28. Li F, Wang Y, Zeller KI, Potter JJ, Wonsey DR, O'Donnell KA, Kim JW, Yustein JT, Lee LA, Dang CV. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol Cell Biol 2005, 25:6225-6234. 10.1128/MCB.25.14.6225-6234.2005, 1168798, 15988031.
29. Douglas NC, Jacobs H, Bothwell AL, Hayday AC. Defining the specific physiological requirements for c-Myc in T cell development. Nat Immunol 2001, 2:307-315. 10.1038/86308, 11276201.
30. Dose M, Khan I, Guo Z, Kovalovsky D, Krueger A, von BH, Khazaie K, Gounari F. c-Myc mediates pre-TCR-induced proliferation but not developmental progression. Blood 2006, 108:2669-2677. 10.1182/blood-2006-02-005900, 1895574, 16788099.
31. Lee MS, Hanspers K, Barker CS, Korn AP, McCune JM. Gene expression profiles during human CD4+ T cell differentiation. Int Immunol 2004, 16:1109-1124. 10.1093/intimm/dxh112, 15210650.
32. Soulier J, Clappier E, Cayuela JM, Regnault A, Garcia-Peydro M, Dombret H, Baruchel A, Toribio ML, Sigaux F. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood 2005, 106:274-286. 10.1182/blood-2004-10-3900, 15774621.
33. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC, Behm FG, Pui CH, Downing JR, Gilliland DG, Lander ES, Golub TR, Look AT. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002, 1:75-87. 10.1016/S1535-6108(02)00018-1, 12086890.
34. Asnafi V, Beldjord K, Libura M, Villarese P, Millien C, Ballerini P, Kuhlein E, Lafage-Pochitaloff M, Delabesse E, Bernard O, Macintyre E. Age-related phenotypic and oncogenic differences in T-acute lymphoblastic leukemias may reflect thymic atrophy. Blood 2004, 104:4173-4180. 10.1182/blood-2003-11-3944, 15054041.
35. Bergeron J, Clappier E, Radford I, Buzyn A, Millien C, Soler G, Ballerini P, Thomas X, Soulier J, Dombret H, Macintyre EA, Asnafi V. Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs. Blood 2007, 110:2324-2330. 10.1182/blood-2007-04-079988, 17609427.
36. van Grotel M, Meijerink JP, van Wering ER, Langerak AW, Beverloo HB, Buijs-Gladdines JG, Burger NB, Passier M, van Lieshout EM, Kamps WA, Veerman AJ, van Noesel MM, Pieters R. Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. Leukemia 2008, 22:124-131. 10.1038/sj.leu.2404957, 17928886.
37. Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 2006, 7:678-689. 10.1038/nrm2009, 16921404.
38. Barolo S, Stone T, Bang AG, Posakony JW. Default repression and Notch signaling: Hairless acts as an adaptor to recruit the corepressors Groucho and dCtBP to Suppressor of Hairless. Genes Dev 2002, 16:1964-1976. 10.1101/gad.987402, 186408, 12154126.
39. Oswald F, Kostezka U, Astrahantseff K, Bourteele S, Dillinger K, Zechner U, Ludwig L, Wilda M, Hameister H, Knochel W, Liptay S, Schmid RM. SHARP is a novel component of the Notch/RBP-Jκ signalling pathway. EMBO J 2002, 21:5417-5426. 10.1093/emboj/cdf549, 129081, 12374742.
40. Borggrefe T, Oswald F. The Notch signaling pathway: transcriptional regulation at Notch target genes. Cell Mol Life Sci 2009, 66:1631-1646. 10.1007/s00018-009-8668-7, 19165418.
41. Fraga MF, Berdasco M, Ballestar E, Ropero S, Lopez-Nieva P, Lopez-Serra L, Martin-Subero JI, Calasanz MJ, Lopez dS I, Setien F, Casado S, Fernandez AF, Siebert R, Stifani S, Esteller M. Epigenetic inactivation of the Groucho homologue gene TLE1 in hematologic malignancies. Cancer Res 2008, 68:4116-4122. 10.1158/0008-5472.CAN-08-0085, 18519670.
42. Agrawal S, Archer C, Schaffer DV. Computational models of the Notch network elucidate mechanisms of context-dependent signaling. PLoS Comput Biol 2009, 5:e1000390. 10.1371/journal.pcbi.1000390, 2680760, 19468305.
43. Grbavec D, Stifani S. Molecular interaction between TLE1 and the carboxyl-terminal domain of HES-1 containing the WRPW motif. Biochem Biophys Res Commun 1996, 223:701-705. 10.1006/bbrc.1996.0959, 8687460.
44. Hasson P, Paroush Z. Crosstalk between the EGFR and other signalling pathways at the level of the global transcriptional corepressor Groucho/TLE. Br J Cancer 2006, 94:771-775. 10.1038/sj.bjc.6603019, 2361374, 16508633.
45. Orian A, Delrow JJ, Rosales Nieves AE, Abed M, Metzger D, Paroush Z, Eisenman RN, Parkhurst SM. A Myc-Groucho complex integrates EGF and Notch signaling to regulate neural development. Proc Natl Acad Sci USA 2007, 104:15771-15776. 10.1073/pnas.0707418104, 2000393, 17898168.
46. Buscarlet M, Stifani S. The 'Marx' of Groucho on development and disease. Trends Cell Biol 2007, 17:353-361. 10.1016/j.tcb.2007.07.002, 17643306.
47. Dayyani F, Wang J, Yeh JR, Ahn EY, Tobey E, Zhang DE, Bernstein ID, Peterson RT, Sweetser DA. Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival. Blood 2008, 111:4338-4347. 10.1182/blood-2007-07-103291, 2288729, 18258796.
48. Smith ST, Jaynes JB. A conserved region of engrailed shared among all en-, gsc-, Nk1-, Nk2- and msh-class homeoproteins mediates active transcriptional repression in vivo. Development 1996, 122:3141-3150. 2729110, 8898227.
49. Riz I, Lee HJ, Baxter KK, Behnam R, Hawley TS, Hawley RG. Transcriptional activation by TLX1/HOX11 involves Gro/TLE corepressors. Biochem Biophys Res Commun 2009, 380:361-365. 10.1016/j.bbrc.2009.01.099, 2654413, 19250647.
50. Riz I, Hawley TS, Johnston H, Hawley RG. Role of TLX1 in T-cell acute lymphoblastic leukaemia pathogenesis. Br J Haematol 2009, 145:140-143. 10.1111/j.1365-2141.2008.07556.x, 2657812, 19133982.
51. Teramoto H, Miwa H, Patel V, Letwin N, Castellone MD, Imai N, Shikami M, Imamura A, Gutkind JS, Nitta M, Lee NH. Gene expression changes in a patient presenting nonleukaemic nasal granulocytic sarcoma to acute myelogenous leukaemia using 40 K cDNA microarray. Clin Lab Haematol 2006, 28:262-266. 10.1111/j.1365-2257.2006.00803.x, 16898967.
52. Lee JK, Bussey KJ, Gwadry FG, Reinhold W, Riddick G, Pelletier SL, Nishizuka S, Szakacs G, Annereau JP, Shankavaram U, Lababidi S, Smith LH, Gottesman MM, Weinstein JN. Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells. Genome Biol 2003, 4:R82. 10.1186/gb-2003-4-12-r82, 329421, 14659019.
53. Owens BM, Zhu YX, Suen TC, Wang PX, Greenblatt JF, Goss PE, Hawley RG. Specific homeodomain-DNA interactions are required for HOX11-mediated transformation. Blood 2003, 101:4966-4974. 10.1182/blood-2002-09-2857, 12586625.
54. Rice KL, Kees UR, Greene WK. Transcriptional regulation of FHL1 by TLX1/HOX11 is dosage cell-type and promoter context-dependent. Biochem Biophys Res Commun 2008, 367:707-713. 10.1016/j.bbrc.2007.12.005, 18073142.
55. Greene WK, Bahn S, Masson N, Rabbitts TH. The T-cell oncogenic protein HOX11 activates Aldh1 expression in NIH 3T3 cells but represses its expression in mouse spleen development. Mol Cell Biol 1998, 18:7030-7037. 109285, 9819390.
56. McMurray HR, Sampson ER, Compitello G, Kinsey C, Newman L, Smith B, Chen SR, Klebanov L, Salzman P, Yakovlev A, Land H. Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype. Nature 2008, 453:1112-1116. 10.1038/nature06973, 2613942, 18500333.
57. Gupta-Rossi N, Le BO, Gonen H, Brou C, Logeat F, Six E, Ciechanover A, Israel A. Functional interaction between SEL-10, an F-box protein and the nuclear form of activated Notch1 receptor. J Biol Chem 2001, 276:34371-34378. 10.1074/jbc.M101343200, 11425854.
58. Margolin AA, Palomero T, Sumazin P, Califano A, Ferrando AA, Stolovitzky G. ChIP-on-chip significance analysis reveals large-scale binding and regulation by human transcription factor oncogenes. Proc Natl Acad Sci USA 2009, 106:244-249. 10.1073/pnas.0806445106, 2613038, 19118200.
59. Dohda T, Maljukova A, Liu L, Heyman M, Grander D, Brodin D, Sangfelt O, Lendahl U. Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines. Exp Cell Res 2007, 313:3141-3152. 10.1016/j.yexcr.2007.04.027, 17560996.
60. Riz I, Hawley RG. G1/S transcriptional networks modulated by the HOX11/TLX1 oncogene of T-cell acute lymphoblastic leukemia. Oncogene 2005, 24:5561-5575. 10.1038/sj.onc.1208727, 2408753, 15897879.
61. Zhou X, Benson KF, Ashar HR, Chada K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 1995, 376:771-774. 10.1038/376771a0, 7651535.
62. Zhou X, Benson KF, Przybysz K, Liu J, Hou Y, Cherath L, Chada K. Genomic structure and expression of the murine Hmgi-cgene. Nucleic Acids Res 1996, 24:4071-4077. 10.1093/nar/24.20.4071, 146186, 8918814.
63. Li O, Li J, Droge P. DNA architectural factor and proto-oncogene HMGA2 regulates key developmental genes in pluripotent human embryonic stem cells. FEBS Lett 2007, 581:3533-3537. 10.1016/j.febslet.2007.06.072, 17624332.
64. Wong DJ, Liu H, Ridky TW, Cassarino D, Segal E, Chang HY. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2008, 2:333-344. 10.1016/j.stem.2008.02.009, 2628721, 18397753.
65. Gomez-Curet I, Perkins RS, Bennett R, Feidler KL, Dunn SP, Krueger LJ. c-Myc inhibition negatively impacts lymphoma growth. J Pediatr Surg 2006, 41:207-211. 10.1016/j.jpedsurg.2005.10.025, 16410134.
66. Huang MJ, Cheng YC, Liu CR, Lin S, Liu HE. A small-molecule c-Myc inhibitor 10058-F4, induces cell-cycle arrest apoptosis, and myeloid differentiation of human acute myeloid leukemia. Exp Hematol 2006, 34:1480-1489. 10.1016/j.exphem.2006.06.019, 17046567.
67. Tworkowski KA, Salghetti SE, Tansey WP. Stable and unstable pools of Myc protein exist in human cells. Oncogene 2002, 21:8515-8520. 10.1038/sj.onc.1205976, 12466972.
68. McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD, Cole MD. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 1998, 94:363-374. 10.1016/S0092-8674(00)81479-8, 9708738.
69. Rogulski K, Li Y, Rothermund K, Pu L, Watkins S, Yi F, Prochownik EV. Onzin, a c-Myc-repressed target promotes survival and transformation by modulating the Akt-Mdm2-p53 pathway. Oncogene 2005, 24:7524-7541. 10.1038/sj.onc.1208897, 16170375.
70. Cox CV, Martin HM, Kearns PR, Virgo P, Evely RS, Blair A. Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia. Blood 2007, 109:674-682. 10.1182/blood-2006-06-030445, 17003368.
71. Borgulya P, Kishi H, Uematsu Y, von Boehmer H. Exclusion and inclusion of α and β T cell receptor alleles. Cell 1992, 69:529-537. 10.1016/0092-8674(92)90453-J, 1316241.
72. Bassing CH, Swat W, Alt FW. The mechanism and regulation of chromosomal V(D)J recombination. Cell 2002, 109(Suppl):S45-S55. 10.1016/S0092-8674(02)00675-X, 11983152.
73. Dear TN, Sanchez-Garcia I, Rabbitts TH. The HOX11 gene encodes a DNA-binding nuclear transcription factor belonging to a distinct family of homeobox genes. Proc Natl Acad Sci USA 1993, 90:4431-4435. 10.1073/pnas.90.10.4431, 46525, 8099440.
74. Masson N, Greene WK, Rabbitts TH. Optimal activation of an endogenous gene by HOX11 requires the NH2-terminal 50 amino acids. Mol Cell Biol 1998, 18:3502-3508. 108931, 9584190.
75. Hoffmann K, Dixon DN, Greene WK, Ford J, Taplin R, Kees UR. A microarray model system identifies potential new target genes of the proto-oncogene HOX11. Genes Chromosomes Cancer 2004, 41:309-320. 10.1002/gcc.20104, 15384172.
76. Riz I, Akimov SS, Eaker SS, Baxter KK, Lee HJ, Mariño-Ramírez L, Landsman D, Hawley TS, Hawley RG. TLX1/HOX11-induced hematopoietic differentiation blockade. Oncogene 2007, 26:4115-4123. 10.1038/sj.onc.1210185, 1955382, 17213805.
77. Muhr J, Andersson E, Persson M, Jessell TM, Ericson J. Groucho-mediated transcriptional repression establishes progenitor cell pattern and neuronal fate in the ventral neural tube. Cell 2001, 104:861-873. 10.1016/S0092-8674(01)00283-5, 11290324.
78. Nagel S, Venturini L, Przybylski GK, Grabarczyk P, Meyer C, Kaufmann M, Battmer K, Schmidt CA, Drexler HG, Scherr M, MacLeod RA. NK-like homeodomain proteins activate NOTCH3-signaling in leukemic T-cells. BMC Cancer 2009, 9:371. 10.1186/1471-2407-9-371, 2770077, 19835636.
79. Kleinmann E, Geimer Le Lay AS, Sellars M, Kastner P, Chan S. Ikaros represses the transcriptional response to Notch signaling in T-cell development. Mol Cell Biol 2008, 28:7465-7475. 10.1128/MCB.00715-08, 2593445, 18852286.
80. Hawley RG, Hawley TS, Cantor AB. TLX1 (HOX11) immortalization of embryonic stem cell-derived and primary murine hematopoietic progenitors. Curr Protoc Stem Cell Biol 2008, 7:1F.7.1-1F.7.19.
81. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007, 131:1109-1123. 10.1016/j.cell.2007.10.054, 18083101.
82. Fedele M, Fusco A. HMGA and cancer. Biochim Biophys Acta 2010, 1799:48-54.
83. Pierantoni GM, Santulli B, Caliendo I, Pentimalli F, Chiappetta G, Zanesi N, Santoro M, Bulrich F, Fusco A. HMGA2 locus rearrangement in a case of acute lymphoblastic leukemia. Int J Oncol 2003, 23:363-367.
84. Odero MD, Grand FH, Iqbal S, Ross F, Roman JP, Vizmanos JL, Andrieux J, Lai JL, Calasanz MJ, Cross NC. Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies. Leukemia 2005, 19:245-252. 10.1038/sj.leu.2403605, 15618963.
85. Wang GP, Berry CC, Malani N, Leboulch P, Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M, Bushman FD. Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial. Blood 2010, 115:4356-4366. 10.1182/blood-2009-12-257352, 20228274.
86. Haraguchi N, Inoue H, Tanaka F, Mimori K, Utsunomiya T, Sasaki A, Mori M. Cancer stem cells in human gastrointestinal cancers. Hum Cell 2006, 19:24-29. 10.1111/j.1749-0774.2005.00004.x, 16643604.
87. Sajithlal GB, Rothermund K, Zhang F, Dabbs DJ, Latimer JJ, Grant SG, Prochownik EV. Permanently blocked stem cells derived from breast cancer cell lines. Stem Cells 2010, 28:1008-1018. 10.1002/stem.424, 20506227.
88. Staal FJ, de Ridder D, Szczepanski T, Schonewille T, van der Linden EC, van Wering ER, van der Velden V, van Dongen JJ. Genome-wide expression analysis of paired diagnosis-relapse samples in ALL indicates involvement of pathways related to DNA replication, cell cycle and DNA repair, independent of immune phenotype. Leukemia 2010, 24:491-499. 10.1038/leu.2009.286, 20072147.
89. Cleaver AL, Beesley AH, Firth MJ, Sturges NC, O'Leary RA, Hunger SP, Baker DL, Kees UR. Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study. Mol Cancer 2010, 9:105. 10.1186/1476-4598-9-105, 2879253, 20459861.
90. Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G, Piqani B, Eisenhaure TM, Luo B, Grenier JK, Carpenter AE, Foo SY, Stewart SA, Stockwell BR, Hacohen N, Hahn WC, Lander ES, Sabatini DM, Root DE. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006, 124:1283-1298. 10.1016/j.cell.2006.01.040, 16564017.
91. Hawley TS, Telford WG, Ramezani A, Hawley RG. Four-color flow cytometric detection of retrovirally expressed red, yellow, green and cyan fluorescent proteins. BioTechniques 2001, 30:1028-1034.
92. Hawley TS, Telford WG, Hawley RG. "Rainbow" reporters for multispectral marking and lineage analysis of hematopoietic stem cells. Stem Cells 2001, 19:118-124. 10.1634/stemcells.19-2-118, 11239166.
93. Owens BM, Hawley TS, Spain LM, Kerkel KA, Hawley RG. TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage. Br J Haematol 2006, 132:216-229. 10.1111/j.1365-2141.2005.05850.x, 2431114, 16398656.
94. Strack RL, Strongin DE, Bhattacharyya D, Tao W, Berman A, Broxmeyer HE, Keenan RJ, Glick BS. A noncytotoxic DsRed variant for whole-cell labeling. Nat Methods 2008, 5:955-957. 10.1038/nmeth.1264, 18953349.
95. Pui JC, Allman D, Xu L, DeRocco S, Karnell FG, Bakkour S, Lee JY, Kadesch T, Hardy RR, Aster JC, Pear WS. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 1999, 11:299-308. 10.1016/S1074-7613(00)80105-3, 10514008.
96. Ramezani A, Hawley RG. Generation of HIV-1-based lentiviral vector particles. Curr Protoc Mol Biol 2002, 60:16.22.1-16.22.15.
97. Akimov SS, Ramezani A, Hawley TS, Hawley RG. Bypass of senescence, immortalization and transformation of human hematopoietic progenitor cells. Stem Cells 2005, 23:1423-1433. 10.1634/stemcells.2005-0390, 1360608, 16144874.
98. Krasnoselskaya-Riz I, Spruill A, Chen YW, Schuster D, Teslovich T, Baker C, Kumar A, Stephan DA. Nuclear factor 90 mediates activation of the cellular antiviral expression cascade. AIDS Res Hum Retroviruses 2002, 18:591-604. 10.1089/088922202753747941, 12036489.
99. Teramoto H, Malek RL, Behbahani B, Castellone MD, Lee NH, Gutkind JS. Identification of H-Ras, RhoA, Rac1 and Cdc42 responsive genes. Oncogene 2003, 22:2689-2697. 10.1038/sj.onc.1206364, 12730683.
100. Hu VW, Nguyen A, Kim KS, Steinberg ME, Sarachana T, Scully MA, Soldin SJ, Luu T, Lee NH. Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesis. PLoS One 2009, 4:e5775. 10.1371/journal.pone.0005775, 2685981, 19492049.
101. Teramoto H, Castellone MD, Malek RL, Letwin N, Frank B, Gutkind JS, Lee NH. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12. Oncogene 2005, 24:489-501. 10.1038/sj.onc.1208209, 15516973.
102. Letwin NE, Kafkafi N, Benjamini Y, Mayo C, Frank BC, Luu T, Lee NH, Elmer GI. Combined application of behavior genetics and microarray analysis to identify regional expression themes and gene-behavior associations. J Neurosci 2006, 26:5277-5287. 10.1523/JNEUROSCI.4602-05.2006, 16707780.
103. Goutsias J, Lee NH. Computational and experimental approaches for modeling gene regulatory networks. Curr Pharm Des 2007, 13:1415-1436. 10.2174/138161207780765945, 17504165.
104. Tapocik JD, Letwin N, Mayo CL, Frank B, Luu T, Achinike O, House C, Williams R, Elmer GI, Lee NH. Identification of candidate genes and gene networks specifically associated with analgesic tolerance to morphine. J Neurosci 2009, 29:5295-5307. 10.1523/JNEUROSCI.4020-08.2009, 19386926.